Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.31 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906539 | 0.96 | CYP2C9 (0.43) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL816535 | 0.92 | CYP2C9 (0.39) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL815984 | 0.89 | CYP2C9 (0.36) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL13219123 | 0.87 | CYP2C9 (0.49) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL13219125 | 0.84 | CYP2C9 (0.46) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL20391886 | 0.83 | CYP2C9 (0.52) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL18306895 | 0.81 | CYP2C9 (0.45) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL9060201 | 0.79 | CYP2C9 (0.51) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL4801614 | 0.79 | CYP2C9 (0.51) | CYP2C9MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL13845274 | 0.78 | CYP2C9 (0.48) | CYP2C9MEN1KMT2AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2110390-B1 | POLYMERIZABLE COMPOSITION | ADEKA CORP (JP) | 2014-07-02 | — | — | EP | disclosed |
| US-8197710-B2 | Polymerizable compound and polymerizable composition | ADEKA CORPORATION (JP) | 2012-06-12 | — | — | US | disclosed |
| US-8066906-B2 | Polymerizable compound and polymerizable composition | ADEKA CORPORATION (JP) | 2011-11-29 | — | — | US | disclosed |
| US-7981320-B2 | Polymerizable composition | ADEKA CORPORATION (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7931825-B2 | Polymerizable composition | ADEKA CORPORATION (JP) | 2011-04-26 | — | — | US | disclosed |
| US-7919009-B2 | Polymerizable compounds and polymerizable compositions | ADEKA CORPORATION (JP) | 2011-04-05 | — | — | US | disclosed |
| US-7910021-B2 | Polymerizable optical active compound and polymerizable composition containing the same | ADEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20100320419-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20100294990-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100090163-A1 | POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2010-04-15 | — | — | US | disclosed |
| US-7683203-B2 | Polymerizable compound and composition containing the polymerizable compound | ADEKA CORPORATION (JP) | 2010-03-23 | — | — | US | disclosed |
| US-7683203-B2 | Polymerizable compound and composition containing the polymerizable compound | ADEKA CORPORATION (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20100032621-A1 | POLYMERIZABLE COMPOUNDS AND POLYMERIZABLE COMPOSITIONS | ADEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | ADEKA CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090294730-A1 | POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20090137761-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND HAVING FUSED RING AND HOMO- AND COPOLYMER OF THE POLYMERIZABLE LIQUID CRYSTAL COMPOUND | ADEKA CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20070282087-A1 | Polymerizable Compound And Composition Containing The Polymerizable Compound | ADEKA CORPORATION (JP) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100320419-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | NOS1, NOS2, PYM1 | CYP2C9 248/4885MEN1 503/4885KMT2A 2646/4885 |
| US-20090137761-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND HAVING FUSED RING AND HOMO- AND COPOLYMER OF THE POLYMERIZABLE LIQUID CRYSTAL COMPOUND | CCNL2, PYM1, NLK | CYP2C9 1567/4885MEN1 2131/4885KMT2A 2320/4885 |
| US-20100032620-A1 | POLYMERIZABLE OPTICAL ACTIVE COMPOUND AND POLYMERIZABLE COMPOSITION CONTAINING THE SAME | C1S, PYM1, MCCC2 | CYP2C9 1814/4885MEN1 360/4885KMT2A 3291/4885 |
| US-20100294990-A1 | POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION | PYM1, SCO2, ZYX | CYP2C9 1146/4885MEN1 255/4885KMT2A 1150/4885 |
| US-20100032621-A1 | POLYMERIZABLE COMPOUNDS AND POLYMERIZABLE COMPOSITIONS | CHRM1, CHRM2, CCNE1 | CYP2C9 799/4885MEN1 95/4885KMT2A 2784/4885 |
| US-20090294730-A1 | POLYMERIZABLE COMPOSITION | SCO2, NAT1, CORO1C | CYP2C9 688/4885MEN1 282/4885KMT2A 1092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.